These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2779949)

  • 1. Development of drug resistance in cultured clonogenic leukemic blast cells during the clinical course of myeloblastic leukemia.
    Asano Y; Okamura S; Shibuya T; Morioka E; Hirota Y; Niho Y
    Oncology; 1989; 46(5):339-42. PubMed ID: 2779949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug sensitivity test for acute myeloblastic leukemia by an efficient leukemic blast colony assay using 5637-conditioned medium as a stimulator.
    Asano Y; Okamura S; Shibuya T; Morioka E; Harada M; Akazawa K; Niho Y
    J Med; 1990; 21(6):289-99. PubMed ID: 2093096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse.
    Nara N; Tohda S; Suzuki T; Nagata K; Tanikawa S; Imai Y; Tomiyama J; Shiina S
    Acta Haematol; 1992; 88(1):17-21. PubMed ID: 1414157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of human recombinant granulocyte/macrophage colony-stimulating factor and native granulocyte colony-stimulating factor on clonogenic leukemic blast cells.
    Asano Y; Shibuya T; Okamura S; Yamaga S; Otsuka T; Niho Y
    Cancer Res; 1987 Nov; 47(21):5647-8. PubMed ID: 3499216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia.
    Nara N; Suzuki T; Yamashita Y; Murohashi I; Aoki N
    Cancer Res; 1988 May; 48(9):2348-52. PubMed ID: 3162711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
    Marie JP; Thevenin D; Zittoun R
    Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta).
    Nara N; Tohda S; Nagata K; Suzuki T; Yamashita Y
    Leukemia; 1989 Aug; 3(8):572-7. PubMed ID: 2473359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
    Nara N; Yamashita Y; Murohashi I; Tanikawa S; Imai Y; Aoki N
    Cancer Res; 1987 May; 47(9):2376-9. PubMed ID: 3471325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of recombinant human tumor necrosis factor on the self-renewal capacity of leukemia blast progenitors in acute myeloblastic leukemia.
    Nagata K; Tohda S; Suzuki T; Nara N
    Leukemia; 1989 Sep; 3(9):626-30. PubMed ID: 2761317
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.
    Pinto A; Aldinucci D; Gattei V; Zagonel V; Tortora G; Budillon A; Cho-Chung YS
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):8884-8. PubMed ID: 1329084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A; Olofsson T
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The sensitivity to cytosine arabinoside of the blast progenitors of acute myeloblastic leukemia.
    Nara N; Curtis JE; Senn JS; Tritchler DL; McCulloch EA
    Blood; 1986 Mar; 67(3):762-9. PubMed ID: 3456247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia.
    Campos L; Guyotat D; Jaffar C; Solary E; Archimbaud E; Treille D
    Eur J Haematol; 1992 May; 48(5):254-8. PubMed ID: 1353726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia.
    Nara N; Kurokawa H; Tohda S; Tomiyama J; Nagata K; Tanikawa S
    Exp Hematol; 1995 Aug; 23(9):1030-4. PubMed ID: 7543415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N4-behenoyl-1-beta-D-arabinofuranosylcytosine on blast progenitors of acute myeloblastic leukemia.
    Nara N; Tohda S; Suzuki T; Nagata K; Yamashita Y; Imai Y; Maruyama Y; Tomiyama J
    Cancer Res; 1990 Dec; 50(23):7587-92. PubMed ID: 2253209
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of stem cell factor (SCF) on the in vitro growth of leukemic blast progenitors in acute non-lymphocytic leukemia.
    Nara N; Tanikawa S; Nagata K; Hamaguchi H; Tomiyama J
    Int J Hematol; 1993 Aug; 58(1-2):27-35. PubMed ID: 7693028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pharmacologically relevant concentrations of mitoxantrone on the in vitro growth of leukemic blast progenitors.
    Grant S; Arlin Z; Gewirtz D; Feldman E
    Leukemia; 1991 Apr; 5(4):336-9. PubMed ID: 2027301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of growth potentiating factor(s) for autologous blast cells by acute myeloblastic leukemia cells.
    Murohashi I; Nagata K; Suzuki T; Yamashita Y; Maruyama Y; Nara N
    Cancer Res; 1988 Nov; 48(22):6424-8. PubMed ID: 3263187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terminal differentiation to mature neutrophils and eosinophils in suspension culture of the blast progenitors in acute myeloblastic leukemia.
    Nara N; Tohda S; Suzuki T; Nagata K; Yamashita Y; Imai Y; Morio T; Bessho M; Shibuya A; Adachi Y
    Hematol Pathol; 1990; 4(3):125-34. PubMed ID: 1701767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the protein kinase C activating agent bryostatin 1 on the clonogenic response of leukemic blast progenitors to recombinant granulocyte-macrophage colony-stimulating factor.
    Grant S; Pettit GR; Howe C; McCrady C
    Leukemia; 1991 May; 5(5):392-8. PubMed ID: 2033960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.